A carregar...

A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma

Both the amplification of the gene coding for wild-type (wt) epidermal growth factor receptor (EGFR) and the overexpression of the EGFR deletion mutant, commonly known as EGFRvIII, are hallmarks of glioblastoma. We have recently reported a novel, recombinant immunotoxin, D2C7-(scdsFv)-PE38KDEL, that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chandramohan, Vidyalakshmi, Bigner, Darell D
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3912004/
https://ncbi.nlm.nih.gov/pubmed/24498557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.26852
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!